Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease [3]

New England Journal of Medicine

Volumn 358, Issue 7, 2008, Pages 743-

  Subbiah, Vivek ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; VINBLASTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMBINATION CHEMOTHERAPY; FALSE POSITIVE RESULT; FOLLOW UP; HODGKIN DISEASE; HUMAN; LETTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 39049145323     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc073362     Document Type: Letter

References (1)

1. Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy - is biopsy of FDG-avid lesions still needed? Radiology 2007;244:257-62.